Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Oster

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Epilepsy & Behavior : E&B|August 8, 2007
The impact of seizures and adverse effects on global health ratingsJoyce A Cramer, Nancy A Brandenburg, Xiao Xu, et al.
Clinical Therapeutics|May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapyAriel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
European Journal of Pain (London, England)|June 28, 2005
Treatment of peripheral neuropathic pain: a simulation modelMontserrat Vera-Llonch, Ellen Dukes, Thomas E Delea, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Is sepsis accurately coded on hospital bills?Daniel A Ollendorf, A Mark Fendrick, Karen Massey, et al.
Diabetes Care|October 28, 2003
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort studyThomas E Delea, John S Edelsberg, May Hagiwara, et al.
Clinical Drug Investigation|May 17, 2007
Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical CareRamy A Mahmoud, Luella M Engelhart, Carmela C Janagap, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2009
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspectiveMontserrat Vera-Llonch, Ellen Dukes, Javier Rejas, et al.
The Clinical Journal of Pain|December 24, 2010
Economic costs of nonmedical use of prescription opioidsRyan N Hansen, Gerry Oster, John Edelsberg, et al.
Infection Control and Hospital Epidemiology|January 9, 2008
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsJohn Edelsberg, Ariel Berger, David J Weber, et al.
The Annals of Pharmacotherapy|January 10, 2008
Blood pressure control in patients initiating antihypertensive therapyDerek Weycker, John Edelsberg, Gabor Vincze, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Epilepsy & Behavior : E&B|August 8, 2007
The impact of seizures and adverse effects on global health ratingsJoyce A Cramer, Nancy A Brandenburg, Xiao Xu, et al.
Clinical Therapeutics|May 18, 2012
Utilization and cost in clinical practice of darbepoetin alfa and epoetin alfa for anemia concomitant with chemotherapyAriel Berger, Claudia Lord, Patricia K Corey-Lisle, et al.
European Journal of Pain (London, England)|June 28, 2005
Treatment of peripheral neuropathic pain: a simulation modelMontserrat Vera-Llonch, Ellen Dukes, Thomas E Delea, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 29, 2002
Is sepsis accurately coded on hospital bills?Daniel A Ollendorf, A Mark Fendrick, Karen Massey, et al.
Diabetes Care|October 28, 2003
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort studyThomas E Delea, John S Edelsberg, May Hagiwara, et al.
Clinical Drug Investigation|May 17, 2007
Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical CareRamy A Mahmoud, Luella M Engelhart, Carmela C Janagap, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2009
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspectiveMontserrat Vera-Llonch, Ellen Dukes, Javier Rejas, et al.
The Clinical Journal of Pain|December 24, 2010
Economic costs of nonmedical use of prescription opioidsRyan N Hansen, Gerry Oster, John Edelsberg, et al.
Infection Control and Hospital Epidemiology|January 9, 2008
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsJohn Edelsberg, Ariel Berger, David J Weber, et al.
The Annals of Pharmacotherapy|January 10, 2008
Blood pressure control in patients initiating antihypertensive therapyDerek Weycker, John Edelsberg, Gabor Vincze, et al.
Pageof 12